Shanghai, China

Shichao Ma

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Shichao Ma: Innovator in Pyrimidine-Fused Cyclic Compounds

Introduction

Shichao Ma is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine-fused cyclic compounds. His research focuses on the preparation methods and applications of these compounds in treating diseases associated with abnormal SHP2 activity.

Latest Patents

Shichao Ma holds a patent for a pyrimidine-fused cyclic compound, which includes a preparation method and its applications. The patent details a compound or a pharmaceutically acceptable salt, hydrate, prodrug, stereoisomer, solvate, or isotope-labeled compound. This invention is aimed at developing a medicament for the prevention and/or treatment of conditions linked to abnormal SHP2 activity.

Career Highlights

Throughout his career, Shichao Ma has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Blueray Therapeutics (Shanghai) Co., Ltd. and Shanghai Blueray Biopharma Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Shichao Ma has collaborated with esteemed colleagues in his field, including Bin Zou and Xianlei Fu. These partnerships have fostered innovation and have been instrumental in the progress of their shared research endeavors.

Conclusion

Shichao Ma's contributions to the field of medicinal chemistry, particularly through his patent on pyrimidine-fused cyclic compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases related to SHP2 activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…